Bellerophon Therapeutics, Inc.BLPH

Market cap

$146.79K

P/E ratio

	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022
Cash and cash equivalents	6	14	29	17	10	48	25	7
Restricted cash	-	0	0	0	0	0	0	0
Prepaid expenses and other current assets	5	6	3	1	0	0	1	0
Total current assets	29	27	36	17	10	48	25	8
Restricted cash, non-current	0	0	0	0	0	0	0	-
Right of use assets, net	-	-	-	-	2	2	1	0
Property and equipment, net	2	1	1	1	0	0	0	0
Other non-current assets	7	1	0	-	-	0	0	0
Total assets	38	30	37	18	13	50	27	8
Accounts payable	2	3	4	3	3	4	1	1
Accrued research and development	3	3	2	4	2	4	1	3
Accrued expenses	-	-	-	-	-	2	2	1
Operating Lease, Liability, Current	-	-	-	-	1	1	1	0
Total current liabilities	8	6	7	8	8	10	5	5
Long term operating lease liabilities	-	-	-	-	2	1	0	-
Common stock warrant liability	-	5	32	7	0	1	0	-
Total liabilities	8	12	39	15	10	12	5	5
Common Stock, Value, Issued	0	0	1	1	0	0	0	0
Preferred Stock, Value, Issued	-	-	-	-	-	-	-	-
Additional paid-in capital	131	142	176	180	193	253	254	255
Accumulated deficit	-101	-124	-179	-176	-190	-214	-232	-252
Total stockholders' equity	30	18	-3	4	4	38	22	3
Total liabilities and stockholders' equity	38	30	37	18	13	50	27	8